ASTS
AST SpaceMobile, Inc.
ASTS offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
CLFD
Clearfield, Inc.
CLFD has the edge over ASTS overall, supported by lower modeled downside.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CLFD Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Stable | |
| Healthy |
CLFD's balance sheet is currently healthy, and its cash flow is stable, but its revenue and profitability are under pressure.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
CLFD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 13x | N/A | N/A |
| Forward | 35x | $31.27 | — |
| Fair | 37x | N/A | N/A |
| Expensive | 46x | N/A | N/A |
| Current | 223x | $31.27 | — |
Historical ranges are pointers, not guarantees.
CLFD's PE is 223x, but its earnings don't support one, so it isn't a reliable read right now.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
CLFD Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for CLFD, with profitability improving. However, they disagree widely on these estimates.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
CLFD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.89 | — |
| Q2 2026 | -$0.51 | -5200% |
| Q1 2026 | -$0.62 | -$0.48 |
| Q4 2025 | -$0.49 | +$0.14 |
| Q3 2025 | -$0.58 | +$0.27 |
| Q2 2025 | $0.01 | +$0.63 |
| Q1 2025 | -$0.14 | +$0.11 |
| Q4 2024 | -$0.63 | -177% |
| Q3 2024 | -$0.85 | -139% |
CLFD has the edge over ASTS on earnings, with more consistent year-over-year improvement.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over CLFD on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
CLFD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $43.9M | -12% |
| Q1 2026 | $34.4M | -27% |
| Q4 2025 | $34.3M | -3.2% |
| Q3 2025 | $17.6M | -62% |
| Q2 2025 | $49.9M | +2.3% |
| Q1 2025 | $47.2M | +28% |
| Q4 2024 | $35.5M | +3.6% |
| Q3 2024 | $46.8M | -5.9% |
CLFD's revenue has slid since its 2022 peak: $44M last quarter, down 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 5.9% | +2.9 points |
| Q1 2026 | -6% | -6.6 points |
| Q4 2025 | -5.3% | +5.9 points |
| Q3 2025 | 25% | +31 points |
| Q2 2025 | 3% | +7.7 points |
| Q1 2025 | 0.6% | +27 points |
| Q4 2024 | -11% | +13 points |
| Q3 2024 | -6.4% | -9.9 points |
CLFD has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
CLFD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $8.9M | +19% |
| Q1 2026 | -$2.1M | -420% |
| Q4 2025 | -$2.4M | -148% |
| Q3 2025 | $8.9M | -9% |
| Q2 2025 | $7.5M | +184% |
| Q1 2025 | $654K | +$5.9M |
| Q4 2024 | $5.1M | -7.2% |
| Q3 2024 | $9.8M | +82% |
CLFD has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
CLFD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -78.4K shares |
| 1 year | -1.7% | -242K shares |
| 3 years | -11% | -1.7M shares |
| 5 years | -1.6% | -220K shares |
| Available history | +1% | +141K shares |
CLFD has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $897,000 |
| Q1 2026 | $7.3M |
| Q4 2025 | $5.3M |
| Q3 2025 | $12,000 |
| Q2 2025 | $5.7M |
| Q1 2025 | $4.7M |
| Q4 2024 | $6.3M |
| Q3 2024 | — |
CLFD spent $14M buying back its own shares over the past year, down 19% from the year before.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CLFD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -2.5x | Net Cash |
| Q1 2026 | -1.3x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.7x | Net Cash |
| Q2 2025 | -13.5x | Net Cash |
| Q4 2023 | -1.8x | Net Cash |
| Q3 2023 | -0.8x | Net Cash |
| Q2 2023 | -0.5x | Net Cash |
CLFD has more cash than debt.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
CLFD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.5 | Neutral |
| Stochastic | 55.1 | Neutral |
CLFD's weekly RSI is 50 (neutral) and its Stochastic is 55 (neutral).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
CLFD PE vs Technology Sector
| Metric | CLFD | Sector median | Relative |
|---|---|---|---|
| PE | 223x | 28x | 702% above |
| PE % | 94 | 35 | 59 pts above |
CLFD is trading at 223x earnings, a 702% premium to the Technology sector's median of 28x, though its earnings don't support one.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
CLFD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.0 | 1% above |
| 20 week MA | $30.5 | 2.6% above |
| 50 week MA | $31.9 | 2% below |
| 100 week MA | $33.1 | 5.6% below |
| 200 week MA | $35.4 | 12% below |
CLFD has the edge over ASTS on trend strength, trading above more of its moving averages.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
CLFD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.9 | $24.8 | +78% |
| 2021 | $24.8 | $78.5 | +217% |
| 2022 | $78.5 | $95.5 | +22% |
| 2023 | $95.5 | $29.1 | -70% |
| 2024 | $29.1 | $31.1 | +7% |
| 2025 | $31.1 | $30.2 | -3.1% |
| 2026 YTD | $30.2 | $31.3 | +3.6% |
CLFD has the edge over ASTS on returns for 2026, with the stronger performance.